Veeva hosts R&D and Quality Summit spotlighting AI innovations in biopharma operations

Bitget2026/10/08 11:05

Veeva will host its R&D and Quality Summit on Oct. 20-21 in Boston. The agenda highlights AI-driven automation for clinical, regulatory, safety, quality operations, including Veeva Falcon, Vault AI, Development Cloud, Quality Cloud updates. Sessions feature customer case studies from Eli Lilly, Pfizer, Sanofi, UCB, Duke University, the University of Pennsylvania. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610080703PR_NEWS_USPR_____SF66779) on October 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Canaccord Genuity: Lowers Oklo's target price to $66

格隆汇•2026/11/09 07:01

Bernstein: Huang Renxun's Controversy May Increase Nvidia's Regulatory Risks, but Maintains $400 Price Target

Cointime•2026/11/09 06:43

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41